In this issue:
- Class 1 indications for coronary revascularisation in prekidney transplant screening
- Anti-PLA2R antibodies promote endothelial pyroptosis and procoagulant phenotype
- Finerenone in CKD without diabetes
- Finerenone in CKD due to glomerular disease
- Kidney and survival outcomes with semaglutide by CKD severity
- Optimising dialysis vascular access
- Dapagliflozin and AKI after cardiac surgery
- Low-dose rivaroxaban and CV events in advanced kidney disease
- Dialysis disequilibrium syndrome: an underdiagnosed condition?
- Iptacopan in IgA nephropathy
Please login below to download this issue (PDF)